Medical testing services relating to the diagnosis and treatment of disease for assessing the likelihood of patient outcomes and medical treatments

Diagnostic medical testing to determine which cancer patients will or will not respond to EGFR-TKI drugs

Blood-based testing to determine the aggressiveness of a patient's cancer and prognosis on treatments including cytotoxic agents, targeted therapies and immunotherapy